** Shares of Somnomed SOM.AX rise as much as 9.9% to A$0.945, their highest level since February 13, 2023
** Stock posts biggest intraday pct rise since October 20
** Medical device maker reports first-quarter revenue of A$28.7 million ($18.65 million), up 13.5% vs pcp
** Stock up 90.2% YTD, including the session's moves
($1 = 1.5389 Australian dollars)
(Reporting by Anjali Singh in Bengaluru)
((anjali.singh2@thomsonreuters.com; ))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.